Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Authors Ksenia Cassidy, CJ Healy, Eva Henje and Wendy D’Andrea Published March 20, 2024 Abstract Challenging experiences in ayahuasca...
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Dr Anne Schlag, Professor David Nutt and more
Mar 121 min read
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Authors Michael Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Schlag and David Nutt Published March 12, 2024 Background...
Simon Ruffell, Sam Gandy, and more
Feb 282 min read
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
Authors Simon GD Ruffell, Sam Gandy, WaiFung Tsang, Rono Lopez, Nathan O’Rourke, Arsalan Akhtar, Nige Netzband, Jack Hollingdale, Daniel...
Drug Science
Feb 65 min read
Will the war on vaping result in more harm?
Key take-home messages: The disposable vape ban is intended to curb youth vaping, addressing the increasing use of vaping among youth in...
Hannah Dawes
Feb 53 min read
Teaching Children about Vaping
Teaching Children about Vaping. In 2023, over 20% of children in the UK had tried vaping, up from less than 11.2% in 2021.
Professor Fiona Measham
Jan 267 min read
The end of the pilot stage: The long and winding road to drug checking in the UK
All images used in this blog are owned by The Loop Written by – Professor Fiona Measham Founder and Chair of The Loop Chair in...
Sean Matthew Viña
Jan 91 min read
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Minorities’ diminished psychedelic returns: Cardio-metabolic health. Race differences remain a critically understudied gap in psychedelic li
Drug Science
Jan 72 min read
Results from Long COVID trial published
We are delighted to share the news that the results from the Long COVID trial have been published by the British Journal of Clinical Pharmac
Drug Science
Dec 11, 20232 min read
Patients with a terminal diagnosis want to access psilocybin in the UK
Terminal patients are calling for compassionate access to be granted for psilocybin — the psychedelic substance found in fungi known as ‘mag
James Bunn
Dec 11, 20235 min read
Psilocybin for Existential Distress
Read our latest report on why patients experiencing 'Existential Distress'
ought to be permitted access to psilocybin-assisted psychotherap
Tom Cooney and Fiona Measham
Nov 21, 20231 min read
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
The exact number of drug-related deaths at UK music festivals in recent years is unknown, and there are no standard processes for reporting
Anoek Van Vugt, Josjan Zijlmans and more
Sep 1, 20231 min read
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
PTSD in adolescence causes much suffering and has substantial health-care costs. The purpose of this study is to investigate the perspective
Zakaria Belrhiti and Fatima Zohra Serghini
Sep 1, 20232 min read
Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: A qualitative explorative study
Worldwide, approximately there are 15.6 million people who inject drugs. Recently, a rising prevalence of hepatitis C virus among the people
Dr Hannah Thurgur, Dr Anne Schlag, and more
Aug 31, 20231 min read
Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in a range of persistent symptoms impacting everyday funct
Dr Rose Crossin
Aug 21, 20237 min read
A drug harms ranking study for Aotearoa New Zealand
Drug harm is a significant public health burden in Aotearoa New Zealand ; though harms are not evenly distributed across the populati
Benjamin Korman
Jul 31, 20231 min read
Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how
Rising international migration, paired with increasing public support for far-right political parties, poses a growing challenge to the coun
Drug Science
Jul 19, 20233 min read
Reagent Testing Information
Any type of recreational drug use is likely to carry a degree of risk, both long-term and short-term. This is true for legal recreational dr
Dr Fiona Hutton, Dr Geoff Noller and more
Jul 19, 202310 min read
A call for cannabis research reform in New Zealand: Why real world evidence and patients’ voices matter
While cannabis based medicines hold out the promise of much needed relief, at the same time, this often conflicts with many countries’ drug
Drug Science
Jul 11, 20234 min read
Drug Science to launch first study to directly test molecular neuroplasticity effects of DMT in humans
Drug Science to launch first study to directly test molecular neuroplasticity effects of DMT in humans
Sally Turner
Jun 12, 20237 min read
Drugs: What are they good for? - 5-MeO-DMT
5-methoxy-N,N-dimethyltryptamine, or ‘toad venom’ as it’s better known, is a tryptamine psychedelic that occurs naturally in multiple specie
Paul McCrone, Henry Fisher and more
Jun 2, 20232 min read
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
There is growing evidence to support the use of the psychedelic drug psilocybin for difficult-to-treat depression. This paper compares the c
bottom of page